{"id":"W1988262237","doi":"10.1016/j.ygyno.2010.01.013","title":"A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Sorafenib; Internal medicine; Carcinosarcoma; Carcinoma; Gastroenterology; Oncology; Surgery; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004722146,0.00023992,0.001160563,0.0002010638,0.0001352904,0.000002612074,0.0002121558,0.0002533889,0.000590319],"category_scores_gemma":[0.001117056,0.0001484895,0.0001331393,0.0005388568,0.0003754289,0.00003781672,0.0003664891,0.0005092048,0.000002230103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001159685,"about_ca_system_score_gemma":0.0003405357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002963523,"about_ca_topic_score_gemma":0.001853971,"domain_scores_codex":[0.9978774,0.0002616037,0.0008413323,0.0004228246,0.0002381624,0.0003586324],"domain_scores_gemma":[0.9982436,0.0006013302,0.0004192416,0.0004669561,0.0001129078,0.0001559591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2354331,0.2184452,0.1632247,0.000230599,0.0004717509,0.0006558776,0.003067592,0.000004344705,0.1342541,0.0002057659,0.0001554754,0.2438515],"study_design_scores_gemma":[0.673079,0.2260077,0.09026938,0.00001467195,0.000407787,0.00006146995,0.0006240458,0.00004342031,0.004815136,0.0002752824,0.004235013,0.000167191],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942533,0.0001602679,0.000001060855,0.0008576972,0.0007589277,0.003005612,0.0001033463,0.00002118429,0.0008385525],"genre_scores_gemma":[0.9990045,0.00002856528,0.0001780226,0.0002324899,0.0001021315,0.0002987087,0.00001445832,0.00001360511,0.0001274501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4376458,"threshold_uncertainty_score":0.646358,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03029193866582253,"score_gpt":0.3653861351511101,"score_spread":0.3350941964852875,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}